
Dinosaurs could help with future cancer treatments scientists say
Dinosaurs could be important in helping scientists find new cancer discoveries in the future, experts say.Researchers were able to find important structures in an ancient dino fossil, which hadn't been seen before.The new study also suggests that the prehistoric creatures could also play a role in future treatments for humans.That's because dinosaurs could help specialists better understand what the disease looked like tens of millions of years ago.
What did scientists discover?
The eight year study involved researchers from Anglia Ruskin University (ARU) and Imperial College, London.They took a closer look at fossils of a Telmatosaurus transsylvanicus, a duck-billed, plant eating "marsh lizard". In 2016, scientists discovered this dinosaur had a benign tumour in its jaw called an ameloblastoma, which humans can also get.The team put the fossil under a microscope and were surprised by what they found.Dr Biancastella Cereser, from Imperial explained: "What we saw inside - there were some structures, some forms, that looked like blood cells."The team said that they also found that soft tissue and cells are more commonly preserved in ancient remains than previously thought.This could help scientists better understand the diseases that affected prehistoric creatures, including cancer, which could potentially influence how the disease is treated in humans in the future.Professor Justin Stebbing from ARU, who was also involved with the study, added: "If we can understand cancer better, we can come up with better treatments."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Sky News
16 minutes ago
- Sky News
Biotech king Evans lands $50m injection for Ellipses cancer drugs
Sir Christopher Evans, the renowned British biotech entrepreneur, is close to landing $50m (£37m) in funding for a developer of a new portfolio of cancer treatments. Sky News has learnt Sir Christopher, whose previous companies have included Biovex and Chiroscience, is in the advanced stages of securing the capital for Ellipses Pharma. City sources said Middle Eastern and Asian investors had provisionally agreed to provide the bulk of the new funding, which is expected to be committed at a valuation of about $800m (£592m). The capital injection is expected to be the last such fundraising before Sir Christopher seeks an initial public offering for Ellipses Pharma, with Hong Kong the likeliest listing venue. Ellipses' focus on oncology has previously drawn investment from prominent backers including Sir Tom Hunter's investment vehicle, West Coast Capital. The London-based company's board members include an executive from Mubadala, the Abu Dhabi sovereign wealth fund. In December, it announced the launch of a clinical trial programme in the UAE. "This tremendous commitment has led us to the point where our achievements can be brought to bear for the potential benefit of patients in UAE," Sir Christopher said at the time. "In many ways, we can now bring hope and an innovative therapy to people in the UAE and also enable healthcare professionals to collaborate and share research."


Evening Standard
19 minutes ago
- Evening Standard
Three Brits accused of smuggling cocaine in Angel Delight sachets face the death penalty in Bali
The Briton, from Yorkshire, who has no previous convictions, claimed she was forced by a UK-based drugs syndicate to smuggle the drug from Thailand to Bali by threats to the life of one of her two sons in Britain.


BBC News
36 minutes ago
- BBC News
Kelleher completes Brentford switch
Liverpool goalkeeper Caoimhin Kelleher has completed a move to Brentford for a fee of £12.5m, rising to £18m with 26-year-old academy product made 25 league appearances and played in more than 40 cup games, winning two Premier League titles, the Champions League, the FA Cup, two Carabao Cups and the Super also goes down in the club's history books as the only goalkeeper to have won four penalty shootouts as a Liverpool Reds have sold the Republic of Ireland international with Valencia keeper Giorgi Mamardashvili joining them in July to compete for the number one shirt with established first choice Alisson."I don't think it was very difficult for me to leave [Liverpool]," said Kelleher. "I felt for my own career that the time was right for me to go, to be a number one and to play every week."I heard of some interest a number of weeks ago. Once I knew Brentford was in for me, it was definitely one I was really excited about and wanted to do as quickly as possible."